Blog

Nick Vitanza: It’s been a dream to bring better treatments to kids with DIPG and CNS tumors

Photo taken from Nick Vitanza/X

Dec 10, 2023, 17:48

Nick Vitanza: It’s been a dream to bring better treatments to kids with DIPG and CNS tumors

Nick Vitanza, the Director of the Vitanza Lab at the Ben Towne Center for Childhood Cancer Research, posted on X/Twitter:

“It’s been a dream to bring better treatments to kids with DIPG and CNS tumors. It’s thrilling to announce BrainChild Bio a kids first biotech advancing CAR-T cells for CNS tumors (CEO Steve Brugger; CSO Mike Jensen, MD) in partnership with Seattle Children’s Hospital.”

Read more here.
Source: Nick Vitanza/X

biotech BrainChild Bio cancer CAR-T cells Childhood Cancer CNS tumors DIPG Mike Jensen Nick Vitanza OncoDaily Oncology pediatric oncology Seattle Children’s Hospital Steve Brugger

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Fabrice André has been elected as the President of the ESMO for the term 2025-2026

Special Coverage